José Antonio Lluch Rodrigo

Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024

Mónica López‐Lacort, Cintia Muñoz-Quiles, Ainara Mira‐Iglesias et al. · Eurosurveillance · 2024 · 158 citations · Full text

Effectiveness of MF59™-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly

Joan Puig‐Barberà, Javier Díez‐Domingo, Ángel Belenguer‐Varea et al. · Vaccine · 2007 · 94 citations

Vaccinology, Vaccination, Vaccine Development +8

Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain)

Javier Díez‐Domingo, Manuel Ridao-López, M. Victoria Gutiérrez-Gimeno et al. · Vaccine · 2011 · 28 citations

Vaccination, Vaccine Safety, Pharmacoeconomic Assessment +8

Incidence and prevalence of type 1 diabetes in children aged <15 yr in Castilla-Leon (Spain)

MP Bahíllo, F Hermoso, Carlos Ochoa et al. · Pediatric Diabetes · 2007 · 27 citations

Effectiveness of nirsevimab introduction against respiratory syncytial virus in the Valencian Community: A preliminary assessment

Pablo Estrella-Porter, Carolina Blanco-Calvo, Ana Sofia Lameiras-Azevedo et al. · Vaccine · 2024 · 26 citations

Vaccination, Valencian Community, Virus Epidemiology +7